Literature DB >> 21798543

"Who's on first": determining the roster for the key players in the reverse cholesterol transport pathway.

A T Remaley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21798543      PMCID： PMC3788687          DOI： 10.1016/j.atherosclerosis.2011.06.037

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  18 in total

Review 1.  Tangier disease: still more questions than answers.

Authors:  J-R Nofer; A T Remaley
Journal:  Cell Mol Life Sci       Date:  2005-10       Impact factor: 9.261

2.  Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels in vivo.

Authors:  Roshni R Singaraja; Miranda Van Eck; Nagat Bissada; Francesca Zimetti; Heidi L Collins; Reeni B Hildebrand; Anna Hayden; Liam R Brunham; Martin H Kang; Jean-Charles Fruchart; Theo J C Van Berkel; John S Parks; Bart Staels; George H Rothblat; Catherine Fiévet; Michael R Hayden
Journal:  Circulation       Date:  2006-08-28       Impact factor: 29.690

3.  Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.

Authors:  YuZhen Zhang; Jaqueline R Da Silva; Muredach Reilly; Jeffrey T Billheimer; George H Rothblat; Daniel J Rader
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 4.  Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.

Authors:  Vassilis I Zannis; Angeliki Chroni; Monty Krieger
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

Review 5.  Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis.

Authors:  Miranda Van Eck; Marieke Pennings; Menno Hoekstra; Ruud Out; Theo Jc Van Berkel
Journal:  Curr Opin Lipidol       Date:  2005-06       Impact factor: 4.776

6.  Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol.

Authors:  M L Varban; F Rinninger; N Wang; V Fairchild-Huntress; J H Dunmore; Q Fang; M L Gosselin; K L Dixon; J D Deeds; S L Acton; A R Tall; D Huszar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

7.  Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo.

Authors:  Miranda Van Eck; Menno Hoekstra; Ruud Out; I Sophie T Bos; J Kar Kruijt; Reeni B Hildebrand; Theo J C Van Berkel
Journal:  J Lipid Res       Date:  2007-10-22       Impact factor: 5.922

8.  Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse.

Authors:  Anne Braun; Songwen Zhang; Helena E Miettinen; Shamsah Ebrahim; Teresa M Holm; Eliza Vasile; Mark J Post; Danita M Yoerger; Michael H Picard; Joshua L Krieger; Nancy C Andrews; Michael Simons; Monty Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

9.  Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice.

Authors:  Vandana S Dole; Jana Matuskova; Eliza Vasile; Ayce Yesilaltay; Wolfgang Bergmeier; Michael Bernimoulin; Denisa D Wagner; Monty Krieger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-24       Impact factor: 8.311

10.  ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.

Authors:  Mary Jane Thomassen; Barbara P Barna; Achut G Malur; Tracey L Bonfield; Carol F Farver; Anagha Malur; Heidi Dalrymple; Mani S Kavuru; Maria Febbraio
Journal:  J Lipid Res       Date:  2007-09-11       Impact factor: 5.922
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.